You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Omalizumab for the Treatment of Multiple Food Allergies
|
|---|---|
| Published in |
New England Journal of Medicine, February 2024
|
| DOI | 10.1056/nejmoa2312382 |
| Pubmed ID | |
| Authors |
Robert A Wood, Alkis Togias, Scott H Sicherer, Wayne G Shreffler, Edwin H Kim, Stacie M Jones, Donald Y M Leung, Brian P Vickery, J Andrew Bird, Jonathan M Spergel, Ahmar Iqbal, Julie Olsson, Monica Ligueros-Saylan, Alkaz Uddin, Agustin Calatroni, Charmaine Marquis Huckabee, Nicole H Rogers, Nancy Yovetich, Jennifer Dantzer, Kim Mudd, Julie Wang, Marion Groetch, David Pyle, Corinne A Keet, Michael Kulis, Sayantani B Sindher, Andrew Long, Amy M Scurlock, Bruce J Lanser, Tricia Lee, Christopher Parrish, Terri Brown-Whitehorn, Amanda K Rudman Spergel, Maria Veri, Sanaz Daneshfar Hamrah, Erica Brittain, Julian Poyser, Lisa M Wheatley, R Sharon Chinthrajah |
X Demographics
The data shown below were collected from the profiles of 456 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 76 | 17% |
| Spain | 30 | 7% |
| Mexico | 19 | 4% |
| Japan | 19 | 4% |
| United Kingdom | 16 | 4% |
| Canada | 8 | 2% |
| Australia | 6 | 1% |
| Argentina | 5 | 1% |
| France | 4 | <1% |
| Other | 50 | 11% |
| Unknown | 223 | 49% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 356 | 78% |
| Scientists | 54 | 12% |
| Practitioners (doctors, other healthcare professionals) | 42 | 9% |
| Science communicators (journalists, bloggers, editors) | 4 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 62 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Unspecified | 18 | 29% |
| Student > Bachelor | 7 | 11% |
| Other | 5 | 8% |
| Researcher | 3 | 5% |
| Lecturer | 3 | 5% |
| Other | 12 | 19% |
| Unknown | 14 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Unspecified | 18 | 29% |
| Medicine and Dentistry | 17 | 27% |
| Immunology and Microbiology | 4 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Biochemistry, Genetics and Molecular Biology | 1 | 2% |
| Other | 5 | 8% |
| Unknown | 15 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1482. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2024.
All research outputs
#8,234
of 25,807,758 outputs
Outputs from New England Journal of Medicine
#419
of 32,691 outputs
Outputs of similar age
#162
of 335,030 outputs
Outputs of similar age from New England Journal of Medicine
#11
of 260 outputs
Altmetric has tracked 25,807,758 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,691 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 335,030 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 260 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.